ArcherDX Blog



Feb
17
2015

Change is not coming. Change is here. See ArcherDX at TriCon 2015

Join us at Molecular Medicine Tri-Conference 2015 to learn about how Archer™ FusionPlex™ Assays are bridging the gap between NGS and scalable, accurate and comprehensive gene fusion detection.


Jan
12
2015

ArcherDX Launches from QIAGEN Acquisition of Enzymatics

ArcherDX enters a strategic partnership with QIAGEN for distribution of targeted next-generation sequencing assays and Jason Myers, Ph.D., becomes Chief Executive Officer of ArcherDX


Dec
10
2014

The Value of Richer NGS Data Sets Using Anchored Multiplex PCR – Webinar by Brian Kudlow, PhD

In this webinar, Dr. Kudlow discussed catalog and custom Archer™ products built upon the AMP™ technology and reviewed the scope and power of the data generated with this technology.


Oct
7
2014

Archer Analysis Pipeline update, version 3.0

The Archer Analysis Pipeline has been updated from version 2.1 to 3.0 to bring greater functionality, faster analysis and more comprehensive reporting.


Jun
13
2014

Archer Analysis Pipeline updates, Version 2.1

Archer Analysis Pipeline version 2.1 updates include improved detection of complex gene fusions, targeted mutation reporting, improved handling of very deeply sequenced samples, and several bug fixes.


Nov
21
2013

AMP for Targeted NGS Poster

Anchored Multiplex PCR for Targeted Next Generation Sequencing - Poster, AMP 2013

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.